Oncology

Calling the lowest-risk prostate cancers something else may encourage some patients to follow physicians' treatment recommendations of active surveillance and avoid pursuing more aggressive options, according to a growing number of physicians advocating for a change in nomenclature, The Wall…

Researchers have identified 921 chemicals thought to increase the risk of breast cancer and say none should be considered "low hazard" until further investigation is done.

Los Angeles-based Cedars-Sinai is using artificial intelligence to improve prediction of and treatment for pancreatic cancer, according to a Jan. 22 news release. 

Here are 95 oncologists and oncology leaders stepping into new roles in 2024:

In an interactive session hosted by GRAIL at Becker's 11th Annual CEO + CFO Roundtable, Roni Christopher, DHSc, senior director of care delivery at GRAIL, and Adam Whitten, vice president of operations at Mercy (St. Louis), discussed how multi-cancer early…

Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.

This is the first year since the COVID-19 pandemic began that hospitals must independently decide if and how to implement masking, and cancer centers across the country are taking different approaches.

Los Angeles-based UCLA Health appointed Mediget Teshome, MD, chief of breast surgery and director of breast health.

The FDA recently approved the nation's first artificial intelligence-powered medical device that detects skin cancer. 

Drugmakers have their sights set on a class of cancer drugs known as antibody drug conjugates, or ADCs, to drive growth, CNBC reported Jan. 14.